Top compounds associated with response to RNF170


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.073 0.04
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.063 0.05
mRNA AC55649 CTRPv2 pan-cancer AAC -0.076 0.05
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.075 0.05
mRNA Gemcitabine gCSI pan-cancer AAC -0.11 0.05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.05
mRNA MK-2206 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA UNC0638 GDSC1000 pan-cancer AAC 0.057 0.05
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC -0.062 0.05
Download CSV